Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome

Yu Gao,Wujuan Li,Xiaoyu Huang,Yuhong Lyu,Changwu Yue

DOI: https://doi.org/10.3390/microorganisms12050851

IF: 4.5

2024-04-24

Microorganisms

Abstract:Previous investigations have illuminated the significant association between the gut microbiome and a broad spectrum of health conditions, including obesity, diabetes, cardiovascular diseases, and psychiatric disorders. Evidence from certain studies suggests that dysbiosis of the gut microbiota may play a role in the etiology of obesity and diabetes. Moreover, it is acknowledged that dietary habits, pharmacological interventions, psychological stress, and other exogenous factors can substantially influence the gut microbial composition. For instance, a diet rich in fiber has been demonstrated to increase the population of beneficial bacteria, whereas the consumption of antibiotics can reduce these advantageous microbial communities. In light of the established correlation between the gut microbiome and various pathologies, strategically altering the gut microbial profile represents an emerging therapeutic approach. This can be accomplished through the administration of probiotics or prebiotics, which aim to refine the gut microbiota and, consequently, mitigate the manifestations of associated diseases. The present manuscript evaluates the recent literature on the relationship between gut microbiota and metabolic syndrome published over the past three years and anticipates future directions in this evolving field.

microbiology

What problem does this paper attempt to address?

The paper primarily explores the latest advancements in gut microbiota-targeted therapies for the treatment of metabolic syndrome and looks ahead to future research directions. Specifically, the paper focuses on the following aspects:

1. **The relationship between gut microbiota and metabolic syndrome**: The paper points out that there is a significant association between gut microbiota and health conditions such as obesity, diabetes, and cardiovascular diseases. Research has found that dysbiosis of the gut microbiota may play an important role in the development of obesity and diabetes. Additionally, factors such as dietary habits, drug interventions, and psychological stress can also affect the composition of the gut microbiota.

2. **Treatment through modulation of gut microbiota**: Improving the gut microbiota by administering prebiotics or probiotics to alleviate the symptoms of related diseases has become an emerging therapeutic strategy. For example, a fiber-rich diet can increase the number of beneficial bacteria, while the use of antibiotics can reduce these beneficial microbial communities.

3. **The latest research findings**: The paper reviews the research literature on the relationship between gut microbiota and metabolic syndrome over the past 3 years and points out future research directions. These studies not only propose innovative treatment methods but also provide new perspectives for future exploration.

In summary, the paper aims to summarize the research progress in recent years on the relationship between gut microbiota and metabolic syndrome and to explore new methods for treating metabolic syndrome by modulating the gut microbiota.